J&J's long-acting injectable push barrels forward as it adds 2nd large molecule to Midatech pact

Johnson & Johnson is tightening its ties to Midatech, adding a second experimental large molecule to a collaboration that is using technology from inkjet printers to create long-acting injectable medicines.